dilazep has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Excerpt | Relevance | Reference |
---|---|---|
"Dilazep was orally given at 100 mg X 3/day for 8 weeks." | 1.27 | [The effect of dilazep on circulating platelet aggregation in diabetics]. ( Buda, GR; Carleo, R; Cerciello, A; Dell'Aversano, R; Monaco, GP; Trovato, C; Vigilante, M, 1983) |
"Twenty patients with type 2 diabetes, aged 25-65 years were orally given dilazep at 100 mg X 3/day for 56 daily." | 1.27 | [Changes in platelet production of malondialdehyde in diabetics treated with dilazep]. ( Buda, GR; Carleo, R; Cerciello, A; Dell'Aversano, R; Monaco, GP; Trovato, C; Vigilante, M, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carleo, R | 2 |
Buda, GR | 2 |
Cerciello, A | 2 |
Dell'Aversano, R | 2 |
Monaco, GP | 2 |
Trovato, C | 2 |
Vigilante, M | 2 |
Nagai, T | 1 |
Tomizawa, T | 1 |
Mori, M | 1 |
1 trial available for dilazep and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Effect of pancreatic elastase on diabetic nephropathy.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diab | 1993 |
2 other studies available for dilazep and Diabetes Mellitus, Type 2
Article | Year |
---|---|
[The effect of dilazep on circulating platelet aggregation in diabetics].
Topics: Administration, Oral; Adult; Aged; Azepines; Diabetes Mellitus, Type 2; Dilazep; Female; Humans; Mal | 1983 |
[Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
Topics: Adult; Aged; Azepines; Blood Platelets; Diabetes Mellitus, Type 2; Dilazep; Female; Humans; Male; Ma | 1983 |